ALL >> General >> View Article
Delnova Unveils Partnership With Pace Life Sciences To Boost Capabilities
DelNova has announced a strategic partnership with Pace® Life Sciences to serve as their contract development and manufacturing organization (CDMO). This collaboration is aimed at advancing DelNova's candidate Rescue Drug, ReViVox®, designed to address unwanted side effects that may occur after Botulinum Neurotoxin (BoNT) therapy, including well-known US brands like BOTOX®, DYSPORT®, XEOMIN®, and JEUVEAU®.
Pace® Life Sciences brings essential expertise to support DelNova in completing investigational new drug (IND)-enabling research for future FDA submissions. This includes work on formulation, kinetics, and stability. DelNova is actively seeking funding opportunities, both dilutive and non-dilutive, including an application submitted to the Small Business Innovation Research (SBIR) program.
Furthermore, through this partnership with Pace® Life Sciences, DelNova gains the capability to manufacture small Good Manufacturing Practice (GMP) batches of drug products for clinical studies. Pace® Life Sciences, with its specialized CDMO facility in San Diego, excels in complex drug delivery, formulation, and sterile ...
... fill-finish GMP manufacturing.
Mary Gardner, CEO and Founder of DelNova, and Frank Tagliaferri, PhD, Vice President of Pharmaceutical Development at Pace® Life Sciences, are enthusiastic about this collaboration. They bring extensive pharmaceutical development expertise to DelNova's efforts. Currently, there is no available product to reverse unwanted paralysis induced by BoNTs, making ReViVox® potentially the first of its kind to address this medical need.
Pace® Life Sciences is a comprehensive provider of contract CMC development, clinical trials materials manufacturing, regulatory compliance, consulting, and facility support services for the pharmaceutical, biopharmaceutical, and gene therapy industries. DelNova's ReViVox® is poised to address complications arising from off-target muscle paralysis following aesthetic and medical neurotoxin therapies, filling a crucial void in the industry.
This partnership underscores the commitment of both companies to advance medical solutions and improve patient outcomes in the field of neurotoxin therapy.
More Information : https://www.techdogs.com/tech-news/pr-newswire/delnova-unveils-partnership-with-pace-life-sciences-to-boost-capabilities
Add Comment
General Articles
1. Amazon.de Vs Kaufland Vs Allegro Price Monitoring EuAuthor: Actowiz Metrics
2. Cissp Certification: Complete Guide To Requirements, Exam, Cost & Online Training
Author: Passyourcert
3. Reliable Myfitnesspal Api Alternatives For Nutrition Data
Author: webfusion
4. Rcdd Career Opportunities: Build Your Future In Telecommunications
Author: Cert Grow
5. Common Air Conditioning Problems And How To Keep Your System Running Efficiently
Author: airconsmau
6. How Customer Support Outsourcing Improves The Online Shopping Experience
Author: MWA
7. Agentic Ai Course In Hyderabad | Agentic Ai Online
Author: Hari
8. Software Company In Bhubaneswar: How To Choose The Right Technology Partner In 2026
Author: NTSPL Hosting
9. Oscp+ Practice Labs: Build Hands-on Penetration Testing Skills
Author: Oscptraining Seo
10. Indian Retailer Product Data Scraping
Author: IWEB
11. Coinmarketcap Clone Software: Development Process, Architecture, And Business Opportunities
Author: Ryan
12. Carbide Inserts: Types, Applications And How To Choose The Right Insert For Cnc Machining
Author: Metaldur
13. Keratin Treatment In Anna Nagar – A Guide To Professional Hair Smoothing
Author: raj
14. Pourquoi Faire Appel à Une Agence Locale Pour Organiser Un Voyage En Odisha ?
Author: UTTAM
15. Eufy Products Analytics On Amazon Usa For Market Insights
Author: Actowiz Metrics






